327 related articles for article (PubMed ID: 33307314)
1. Inhaled tobramycin for chronic infection with pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis: A systematic review and meta-analysis.
Sangiovanni S; Morales EI; Fernández-Trujillo L
Respir Med; 2021 Jan; 176():106283. PubMed ID: 33307314
[TBL] [Abstract][Full Text] [Related]
2. Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis.
Bilton D; Henig N; Morrissey B; Gotfried M
Chest; 2006 Nov; 130(5):1503-10. PubMed ID: 17099030
[TBL] [Abstract][Full Text] [Related]
3. The Rationale and Evidence for Use of Inhaled Antibiotics to Control Pseudomonas aeruginosa Infection in Non-cystic Fibrosis Bronchiectasis.
Dhand R
J Aerosol Med Pulm Drug Deliv; 2018 Jun; 31(3):121-138. PubMed ID: 29077527
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of long-term inhaled antibiotic for patients with noncystic fibrosis bronchiectasis: a meta-analysis.
Yang JW; Fan LC; Lu HW; Miao XY; Mao B; Xu JF
Clin Respir J; 2016 Nov; 10(6):731-739. PubMed ID: 25620629
[TBL] [Abstract][Full Text] [Related]
5. Bronchiectasis and inhaled tobramycin: A literature review.
Elborn JS; Blasi F; Haworth CS; Ballmann M; Tiddens HAWM; Murris-Espin M; Chalmers JD; Cantin AM
Respir Med; 2022 Feb; 192():106728. PubMed ID: 34998112
[TBL] [Abstract][Full Text] [Related]
6. Microbiological changes observed over 48 weeks of treatment with inhaled liposomal ciprofloxacin in individuals with non-cystic fibrosis bronchiectasis and chronic Pseudomonas aeruginosa lung infection.
VanDevanter DR; Gonda I; Dahms J; Cipolla D; Davis AM; Chalmers JD; Froehlich J
Clin Microbiol Infect; 2019 Dec; 25(12):1532-1538. PubMed ID: 31035017
[TBL] [Abstract][Full Text] [Related]
7. Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa.
Drobnic ME; Suñé P; Montoro JB; Ferrer A; Orriols R
Ann Pharmacother; 2005 Jan; 39(1):39-44. PubMed ID: 15562142
[TBL] [Abstract][Full Text] [Related]
8. [Inhaled colistin in elderly patients with non-cystic fibrosis bronchiectasis and chronic Pseudomonas aeruginosa bronchial infection].
Tabernero Huguet E; Gil Alaña P; Alkiza Basañez R; Hernández Gil A; Garros Garay J; Artola Igarza JL
Rev Esp Geriatr Gerontol; 2015; 50(3):111-5. PubMed ID: 25724860
[TBL] [Abstract][Full Text] [Related]
9. Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials.
Haworth CS; Bilton D; Chalmers JD; Davis AM; Froehlich J; Gonda I; Thompson B; Wanner A; O'Donnell AE
Lancet Respir Med; 2019 Mar; 7(3):213-226. PubMed ID: 30658914
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic therapy for stable non-CF bronchiectasis in adults - A systematic review.
Fjaellegaard K; Sin MD; Browatzki A; Ulrik CS
Chron Respir Dis; 2017 May; 14(2):174-186. PubMed ID: 27507832
[TBL] [Abstract][Full Text] [Related]
11. The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis.
Laska IF; Crichton ML; Shoemark A; Chalmers JD
Lancet Respir Med; 2019 Oct; 7(10):855-869. PubMed ID: 31405826
[TBL] [Abstract][Full Text] [Related]
12. Eradication Therapy against Pseudomonas aeruginosa in Non-Cystic Fibrosis Bronchiectasis.
Orriols R; Hernando R; Ferrer A; Terradas S; Montoro B
Respiration; 2015; 90(4):299-305. PubMed ID: 26340658
[TBL] [Abstract][Full Text] [Related]
13. Eradication of
Blanco-Aparicio M; Saleta Canosa JL; Valiño López P; Martín Egaña MT; Vidal García I; Montero Martínez C
Chron Respir Dis; 2019; 16():1479973119872513. PubMed ID: 31480862
[TBL] [Abstract][Full Text] [Related]
14. Results of Tobramycin Inhalation Therapy in Patients with Noncystic Fibrosis Bronchiectasis with
Tanriverdi E; Yildirim BZ; Gul S; Chousein EGU; Turan D; Çınarka H; Özgül MA; Cetinkaya E
J Aerosol Med Pulm Drug Deliv; 2021 Sep; 34(5):274-279. PubMed ID: 33351705
[No Abstract] [Full Text] [Related]
15. Aerosolized antibiotics for non-cystic fibrosis bronchiectasis.
Rubin BK
J Aerosol Med Pulm Drug Deliv; 2008 Mar; 21(1):71-6. PubMed ID: 18518833
[TBL] [Abstract][Full Text] [Related]
16. Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis.
Barker AF; Couch L; Fiel SB; Gotfried MH; Ilowite J; Meyer KC; O'Donnell A; Sahn SA; Smith LJ; Stewart JO; Abuan T; Tully H; Van Dalfsen J; Wells CD; Quan J
Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):481-5. PubMed ID: 10934074
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of tobramycin inhalation powder in bronchiectasis patients with P. aeruginosa infection: Design of a dose-finding study (iBEST-1).
Loebinger MR; Polverino E; Blasi F; Elborn SJ; Chalmers JD; Tiddens HA; Goossens H; Tunney M; Zhou W; Angyalosi G; Hill AT; Haworth CS;
Pulm Pharmacol Ther; 2019 Oct; 58():101834. PubMed ID: 31433997
[TBL] [Abstract][Full Text] [Related]
18. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group.
Ramsey BW; Pepe MS; Quan JM; Otto KL; Montgomery AB; Williams-Warren J; Vasiljev-K M; Borowitz D; Bowman CM; Marshall BC; Marshall S; Smith AL
N Engl J Med; 1999 Jan; 340(1):23-30. PubMed ID: 9878641
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Inhaled Antibiotics for the Treatment of Chronic Pseudomonas aeruginosa Lung Infection in Patients With Cystic Fibrosis: Systematic Literature Review and Network Meta-analysis.
Elborn JS; Vataire AL; Fukushima A; Aballea S; Khemiri A; Moore C; Medic G; Hemels ME
Clin Ther; 2016 Oct; 38(10):2204-2226. PubMed ID: 27692977
[TBL] [Abstract][Full Text] [Related]
20. [Use of inhaled tobramycin in patients with cystic fibrosis].
Chermenskiĭ AG; Gembitskaia TE
Ter Arkh; 2010; 82(8):76-8. PubMed ID: 20873251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]